UnitedHealth Group (UNH) EVP & Chief Legal Officer reports RSU dividend share accrual

Rhea-AI Filing Summary

UnitedHealth Group executive Christopher R. Zaetta, EVP & Chief Legal Officer, reported acquiring additional UnitedHealth Group common stock through dividend equivalents on restricted stock units. On 12/16/2025, he acquired 44.528 shares at a price of $0, reflecting reinvested dividends rather than an open-market purchase. These dividend equivalents are subject to the same vesting conditions as the underlying restricted stock units and are forfeited if those units do not vest. Following this transaction, Zaetta beneficially owns 10,327.804 shares of UnitedHealth Group common stock in direct ownership.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zaetta Christopher R

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MN 55344

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/16/2025		A		44.528(1)	A	$0	10,327.804	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Christopher R. Zaetta	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Christopher R. Zaetta report for UNH?

Christopher R. Zaetta, EVP & Chief Legal Officer of UnitedHealth Group, reported acquiring 44.528 shares of common stock on 12/16/2025 through dividend equivalents on restricted stock units.

At what price were the UnitedHealth Group (UNH) shares acquired in this filing?

The 44.528 shares of UnitedHealth Group common stock were acquired at a price of $0, reflecting dividend equivalents credited on outstanding restricted stock units.

How many UnitedHealth Group (UNH) shares does Christopher R. Zaetta own after this transaction?

After the reported transaction, Christopher R. Zaetta beneficially owns 10,327.804 shares of UnitedHealth Group common stock in direct ownership.

What is the nature of the shares reported in this UNH insider filing?

The 44.528 shares represent dividend equivalents paid on outstanding restricted stock units. These dividend equivalents follow the same terms as the restricted stock units and are forfeited if the units do not vest.

What is Christopher R. Zaetta’s role at UnitedHealth Group (UNH)?

Christopher R. Zaetta is an officer of UnitedHealth Group, serving as EVP & Chief Legal Officer, as disclosed in the filing.

Is this UnitedHealth Group (UNH) insider filing for one reporting person or a group?

The document states that the Form is filed by one reporting person, specifically covering the holdings and transaction of Christopher R. Zaetta.